Analysis of fluoroquinolone resistance in clinical isolates of Mycobacterium tuberculosis from India

Journal of Chemotherapy

Volumn 19, Issue 2, 2007, Pages 166-171

  Sulochana, S ^a   Narayanan, S ^a   Paramasivan, C N ^a,b   Suganthi, C ^a   Narayanan, P R ^a  

^a INDIAN COUNCIL OF MEDICAL RESEARCH   (India)

^b FOUNDATION FOR INNOVATIVE NEW DIAGNOSTICS   (Switzerland)

Author keywords

Fluoroquinolones; Gyr A mutations; M. tuberculosis; Mycobacterium tuberculosis

Indexed keywords

CIPROFLOXACIN; DNA TOPOISOMERASE (ATP HYDROLYSING) A; GATIFLOXACIN; LOMEFLOXACIN; MOXIFLOXACIN; OFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SPARFLOXACIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATE; CODON; CONTROLLED STUDY; DRUG DETERMINATION; DRUG SENSITIVITY; ENZYME ANALYSIS; GENE AMPLIFICATION; GENE SEQUENCE; INDIA; MUTATIONAL ANALYSIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN;

EID: 34247895479     PISSN: 1120009X     EISSN: None     Source Type: Journal    
DOI: 10.1179/joc.2007.19.2.166     Document Type: Article

References (23)

1. Tuberculosis Research Centre: Shortening short course chemotherapy. A randomized clinical trial for treatment of smear positive pulmonary tuberculosis with regimens using ofloxacin in the intensive phase. Ind J Tuberc 2002; 49: 27-38
2. Yew WW, Chau CK, Tam CM, Leung CC, Wong PC, Lee J. Outcomes of patients with multidrug-resistant pulmonary tuberculosis treated with ofloxacin/levofloxacin containing regimens. Chest 2000; 117: 744-751.
3. Prasanta RM. Fluoroquinolones in multidrug-resistant tuberculosis. Am J Respir Crit Care Med 2004; 170 (8): 920.
4. Takiff HE, Salazar L, Guerrero C et al. Cloning and nucleotide sequence of Mycobacterium tuberculosis gyr A and gyr B genes and detection of quinolone resistance mutations. Antimicrob Agents Chemother 1994; 38: 773-880.
5. Hooper D, Wolfson JS. Mechanisms of bacterial resistance to quinolones. In Hooper D, Wolfson J eds: Quinolones, Antimicrobial agents. Washington, DC. American Society for Microbiology 1993; 97-118.
6. Mitchison DA, Wallace JG, Bhatia AL, Selkon JB, Lancaster MC. A comparison of the virulence in guinea pigs of South Indian and British tubercle bacilli. Tubercle 1960; 41: 1-22.
7. Middlebrook G, Cohn ML. Some observations on the pathogenicity of isoniazid-resistant variants of tubercle bacilli. Science 1953;118: 297-299.
8. Joseph S, Mitchison DA, Ramachandran K, Selkon JB Subbaiah TV. Virulence in the guinea -pig and sensitivity to PAS and thiacetazone of tubercle bacilli from south Indian patients with pulmonary tuberculosis. Tubercle 1964; 45 (4) 354-359.
9. Grange JM, Aber VR, Allen BW, Mitchison DA, Goren MB. The correlation of bacteriophage types of Mycobacterium tuberculosis with guinea pig virulence and in vitro indicators of virulence. J Gen Microbiol. 1978; 108 (1): 1-7
10. Bhatia AL. Characteristics of Indian tubercle bacilli. Ind J Chest Dis 1961; 3: 147-153.
11. Sujatha N, Sulochana D, Renu G et al. Molecular epidemiology of tuberculosis in a rural area of high prevalence in south India; Implications for disease control and prevention. J Clin Microbiol 2002; 40: 4785-4788
12. Cheruvu M, Selvakumar N, Narayanan S, Narayanan PR. Mutations in the rpo B gene of multidrug-resistant Mycobacterium tuberculosis clinical isolates from India. J Clin Microbiol 2001; 39:2987-2990.
13. NCCLS. Susceptibility testing of Mycobacteria, Nocardia and Other Aerobic Actinomycetes. NCCLS document. 2003; M24-A 23: No. 18, 1-71
14. Sulochana S, Venkataraman P, Paramasivan CN. Evaluation of various methods of susceptibility to ofloxacin in strains of Mycobacterium tuberculosis. Ind J Med Res 1999; 110: 186-189.
15. Sulochana S, Fathima Rahman, Paramasivan CN. In vitro activity of fluoroquinolones against Mycobacterium tuberculosis. J Chemother 2005; 17 (2): 169-173.
16. World Health Organization. Anti tuberculosis drug resistance in the world. WHO/TB/97.229
17. Hermans, Schuitema PWM, Van Soolingen ARJ et al Specific detection of Mycobacterium tuberculosis complex strains by polymerase chain reaction. J Clin Microbiol 1990; 28: Issue 6 pg 1204-1213.
18. Siddiqi N, Shamim MN, Jain NK et al. Molecular Genetic analysis of multi drug resistance in Indian isolates of Mycobacterium tuberculosis. Mem inst Oswaldo Cruz, Rio de Janeiro, 1998; 93: 589-594
19. Augustine FBC, Wing WY, Edward WCC, Miu LC, Mamie MMH, Raphael CYC. Multiplex PCR amplimer conformation analysis for rapid detection of gyr A mutations in fluoroquinolone resistant Mycobacterium tuberculosis clinical isolates. Antimicrob Agents Chemother 2004; 48: 596-601.
20. Kocagoz T, Hackbarth CJ, Unsal I, Rosenberg EY, Nikaido H, Chambers HF. Gyrase mutations in laboratory selected, fluoroquinolone resistant mutants of Mycobacterium tuberculosis H37Ra. Antimicrob Agents chemother 1996; 40:1768-1774.
21. Siddiqi N, Shamim MN, Hussain S et al. Molecular characterization of multidrug resistant isolates of Mycobacterium tuberuculosis from patients in North India. Antimicrob Agents Chemother 2002; 46: 443-450.
22. Giannoni F, Iona E, Sementilli F et al. Evaluation of a new line probe assay for rapid identification of gyr A mutations in Mycobacterium tuberculosis. Antimicrob Agents Chemother 2005; 49: 2928-2933.
23. Aubry A, Veziris N, Cambau E, Pernot CT, Jarlier V, Fisher LM. Novel gyrase mutations in quinolones - resistant and hypersusceptible clinical isolates of Mycobacterium tuberculosis: Functional analysis of mutant enzymes. Antimicrob Agents Chemother 2006; 50: 104-112.